India’s first ‘Blue Tongue’ vaccine launched

India’s first ‘Blue Tongue’ vaccine launched
Highlights

Indian Immunologicals Limited (IIL), a wholly owned subsidiary of the National Dairy Development Board (NDDB), introduced the first ‘Blue Tongue’ disease vaccine which would be developed in India. IIL is a leading bio pharmaceutical company and the largest veterinary vaccine manufacturer and exporter.

Indian Immunologicals Limited (IIL), a wholly owned subsidiary of the National Dairy Development Board (NDDB), introduced the first ‘Blue Tongue’ disease vaccine which would be developed in India. IIL is a leading bio pharmaceutical company and the largest veterinary vaccine manufacturer and exporter.

Blue tongue is a viral disease which mainly affects sheep. Goats, camels and cattle are also affected by this disease. India is endemic to the Blue Tongue disease since it has a large population of about 70 million sheep.

There are 24 viral strains prevalent in the world. However, in India, only five strains are predominant. Blue tongue disease results in more than 30 per cent mortality and causes high level of morbidity. Until now, no vaccine has been developed to protect against the strains prevalent in India. Treatment of Blue tongue disease is also expensive.

IIL developed the inactivated Blue Tongue disease vaccine in collaboration with TANUVAS (Tamilnadu University of Veterinary and Animal sciences) & ICAR and conducted extensive multi-centric trials in reputed institutes to prove its safety and efficacy. RAKSHA-BLU is the brand name of the IIL’s Blue Tongue vaccine. RAKSHA-BLU is a pentavalent vaccine, incorporating the five strains of Blue Tongue virus prevalent in India. RAKSHA-BLU would be available to farmers at Rs 5 per dose.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
More Stories


Top